Skip to content

Observation on the efficacy of transcutaneous auricular-vagus nerve electrical stimulation in patients with dysphagia in Alzheimer 's disease

Observation on the efficacy of transcutaneous auricular-vagus nerve electrical stimulation in patients with dysphagia in Alzheimer 's disease

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084142
Enrollment
Unknown
Registered
2024-05-11
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer 's disease patients with dysphagia

Interventions

Control group:oropharyngeal sensory training, oral exercise training, tongue exercise training, Mendelssohn training, head and neck training
Test team:On the basis of training in the control group, transcutaneous auricular vagus nerve electrical stimulation was performed.

Sponsors

Zhejiang Provincial People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: AD conforms to the relevant diagnostic criteria in ' Neurology ( 8th edition ) ', and the severity of the disease is in the mild to moderate stage ; 2 TCM diagnosis refers to the ' Guiding Principles for Clinical Research of New Drugs of Traditional Chinese Medicine ', and the syndrome differentiation is phlegm and blood stasis syndrome. The main symptoms are slow response, mental decline, and forgetfulness. Secondary symptoms : tinnitus and deafness, dizziness, chest tightness, shortness of breath, sticky mouth, dark complexion ; dark purple tongue with ecchymosis, greasy fur or less fur, deep fine or astringent pulse ; the main symptoms combined with any two secondary symptoms can be diagnosed ; 3 aged 55-80 years old ; 4 can cooperate with swallowing function examination and questionnaire survey ; 5 The existence of oropharyngeal dysphagia was confirmed by swallowing angiography ; 6 not taking antipsychotic drugs.

Exclusion criteria

Exclusion criteria: 1 Dementia caused by cerebrovascular disease, Parkinson 's disease and hypothyroidism ; 2 Clinical Dementia Rating ( CDR ) = 3 ] ; 3 patients with obstructive pulmonary disease, pulmonary infection and other factors affecting blood oxygen saturation ; 4 oropharyngeal, esophageal organic lesions, or stroke, Parkinson 's disease, multiple sclerosis, myasthenia gravis, metabolic myopathy and other neurological diseases that may affect swallowing ; 5 patients with severe visual or hearing impairment.

Design outcomes

Primary

MeasureTime frame
the scores of Standardized Swallowing Assessment , SSA;Swallowing related physiological parameters;

Secondary

MeasureTime frame
Leakage aspiration grading;Quality of life in patients with dysphagia;transscranial magnetic stimulation-motor evoked potential;

Countries

China

Contacts

Public ContactLu-Lu,Tong

Zhejiang Provincial People 's Hospital

492556427@qq.com+86 159 5816 7730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026